Jacob Ellison
Chief Analytics Officer at LifeMD
Executive
About Jacob Ellison
Jacob Ellison is LifeMD’s Chief Analytics Officer, appointed on July 31, 2025. He oversees the company’s data strategy, AI innovation, and FP&A, moving up from Vice President of Analytics based on demonstrated impact linking data insights to patient outcomes and business value .
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| LifeMD | Vice President of Analytics | Prior to 2025 → 2025 | Recognized for translating analytics into operational and patient-impact value; promotion tied to expanding oversight of data, AI, and FP&A |
External Roles
- None disclosed in LifeMD’s public filings reviewed for this period.
Investment Implications
- Elevation to Chief Analytics Officer signals a push to institutionalize data-driven operating discipline; his portfolio spans monetization analytics (FP&A), AI productization, and platform data strategy—areas that directly affect CAC, retention, and margin quality in telehealth and pharmacy operations .
- Near-term compensation, ownership, and contract transparency are limited for this executive (not named among NEOs in the latest proxy excerpts surfaced), constraining pay-for-performance assessment and insider-selling pressure analysis; monitor upcoming proxies and any Form 4 activity to gauge alignment and retention risk .
Best AI for Equity Research
Performance on expert-authored financial analysis tasks
Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%